Tremfya 100 mg/mL single-dose One-Press patient-controlled injector Images

Generic Name: guselkumab

This medication has been identified as Tremfya 100 mg/mL single-dose One-Press patient-controlled injector. It is supplied by Janssen Biotech, Inc.

Tremfya is used in the treatment of Ulcerative Colitis; Psoriatic Arthritis; Crohn's Disease; Plaque Psoriasis; Psoriasis and belongs to the drug class interleukin inhibitors. Tremfya 100 mg/mL single-dose One-Press patient-controlled injector is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Tremfya

Generic Name

guselkumab

Strength

100 mg/mL single-dose One-Press patient-controlled injector

Availability

Prescription only

Drug Class

Interleukin inhibitors

CSA Schedule

Not a controlled drug

Labeler / Supplier

Janssen Biotech, Inc.

National Drug Code (NDC)

57894-0640

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer